Belite Bio, Inc (BLTE) Misses Q1 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q1 EPS of ($0.31), $0.05 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Belite Bio (BLTE) Reiterated at Buy by Benchmark on Tinlarebant NDA Acceptance by FDA
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results